The Current Status of Fetal Interventions for Congenital Anomalies (PEDS)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Pediatric Surgery. Learn more about ACS Accreditation/Verification Requirements.
This panel of experts will address the climate surrounding fetal intervention for congenital anomalies. The topics will include discussions involving cystic lung lesions, teratomas, or other masses leading to hydrops, urologic disorders, and myelomeningocele.
Moderator: Oluyinka O. Olutoye, MBChB, FACS, Houston, TX
Co-Moderator: Hanmin Lee, MD, FACS, San Francisco, CA
Fetal Therapy for Urologic Anomalies
Eric Bradley Jelin, MD, FACS, FAAP, location
Advances in the In-Utero Repair of Spina Bifida
William E. Whitehead, MD, location
Update on Fetal Tracheal Occlusion for Congenital Diaphragmatic Hernia and Other Fetal Interventions
Oluyinka O. Olutoye, MBChB, PhD, FACSD, location
Sponsored by the Advisory Council for Pediatric Surgery
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Eric Bradley Jelin MD, FACS, FAAP - Nothing to Disclose
Hanmin Lee, MD, FACS - Sira medical: Stock options: Advisor
Oluyinka O. Olutoye, MBChB, PhD, FACS - Cambridge publishers: Spouse - Royalty: Editor; Up-To-Date: Royalty: Author; Covidien/Medtronic: Research grant: PI; Mallinkrodt Inc: Research Grant: PI
William E. Whitehead MD - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit